News

Kayaking for Meso 2017: A Fundraising Event in New York

On Satuday, September 9, 2017, at 9:30 am, a truly spectacular occurrence can be witnessed within the banks of the Hudson river: Hundreds of kayakers will descend down the river from Stillwater, NY to Halfmoon, NY to raise awareness and funds for mesothelioma research, education, support, and advocacy. This 8-mile paddle takes between 3 and […]


Bruce Waite 5K Run/Walk: Mansfield, Ohio

On Sunday, September 17, at Ontario High School, 457 Shelby Ontario Rd, Mansfield, OH, join our community fundraisers at their annual “Bruce Waite 5K Run/Walk.” The event honors Bruce Waite, a teacher at Mansfield High from 1959-1989, who in 2003 died of mesothelioma, one year after diagnosis.
For the past six years, the Bruce Waite 5k […]


5K Walk to Cure Meso – New York

If you live in the New York area, mark your calendar! This September 17, 2017 at 9 am, join our community member and fundraiser Erica Iacono in Eisenhower Park, East Meadow, NY for all-family 5K Walk to Cure Meso.
Click here to register: https://www.crowdrise.com/5KWALKTOCUREMESO2017
“After 12 years, I still do this event because I want to honor […]


NEWS: Peritoneal Surgeon Moves to Rutgers from University of Maryland

At the end of October of 2017, Dr. H. Richard Alexander, esteemed surgeon specializing in peritoneal mesothelioma, will be moving from his current institution, the University of Maryland, to Rutgers University in New Jersey.  His new position as Chief Surgical Officer will combine administrative as well as clinical duties. As such, Dr. Alexander will also […]


Anetumab Ravtansine Fails to Show Improvement of Progression-Free Survival in Mesothelioma

In a statement released on Sunday, Bayer announced that Anetumab ravtansine, its antibody-drug conjugate (ADC) tested in mesothelioma, has missed its primary endpoint failing to improve progression-free survival in mesothelioma patients.
“Malignant pleural mesothelioma is a very difficult-to-treat tumor, and we had hoped for a better outcome for patients,” said Robert LaCaze, Executive Vice President and […]